Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E–Deficient Mice
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background— The novel phosphate binder sevelamer has been shown to prevent the progression of aortic and coronary calcification in uremic patients. Whether it also decreases the progression of atheromatous plaques is unknown. The aim of our study was to examine the effect of sevelamer administration on the development of atherosclerosis and aortic calcification in the uremic apolipoprotein E–deficient mouse as an established model of accelerated atherosclerosis. Methods and Results— Female mice were randomly assigned to 4 groups: 2 groups of nonuremic mice (sevelamer versus control) and 2 groups of uremic mice (sevelamer versus control). Sevelamer was given at 3% with chow. The increases in serum phosphorus concentration and calcium-phosphorus product observed in uremic control mice were prevented by sevelamer. Serum total cholesterol was increased in the 2 uremic mouse groups and remained unchanged in response to sevelamer. After 8 weeks of sevelamer treatment, uremic mice exhibited a significantly lower degree of atherosclerosis ( P <0.001) and vascular calcification than uremic control mice. Of interest, sevelamer exerted an effect on both intima and media calcification ( P =0.005) in uremic mice. Among possible mechanisms involved, we found no evidence for the modulation by sevelamer of inflammation or selected uremic toxins. In contrast, nitrotyrosine staining as a measure of oxidative damage was significantly decreased in response to sevelamer treatment in control and uremic mice ( P <0.005). Conclusions— Sevelamer delays not only vascular calcification but also atherosclerotic lesion progression in uremic apolipoprotein E–deficient mice. It opens the possibility of a cholesterol-independent action of sevelamer on atheroma formation via effects on mineral metabolism, oxidative stress, or both.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Uremia Accelerates both Atherosclerosis and Arterial Calcification in Apolipoprotein E Knockout Mice
Massy, Z. A., Ivanovski, O., Nguyen-Khoa, T., Angulo, J., Szumilak, D., Mothu, N., Phan, O., Daudon, M., Lacour, B., Dru[Combining Diaeresis]eke, T. B., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004060495 · Cited by 203
Self-citationThe Apolipoprotein E Knockout Mouse: A Model Documenting Accelerated Atherogenesis In Uremia
Buzello, M., Törnig, J., Faulhaber, J., Ehmke, H., Ritz, E., & Amann, K. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000045048.71975.fc · Cited by 167
Cited by
Uremic toxins originating from colonic microbial metabolism
Evenepoel, P., Meijers, B. K. I., Bammens, B. R. M., & Verbeke, K. (2009) · Kidney International · doi:10.1038/ki.2009.402 · Cited by 445
Qunibi, W., Moustafa, M., Muenz, L. R., He, D. Y., Kessler, P. D., Diaz-Buxo, J. A., & Budoff, M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.02.298 · Cited by 311
Evenepoel, P., Poesen, R., & Meijers, B. (2017) · Pediatric Nephrology · doi:10.1007/s00467-016-3527-x · Cited by 305
Oxidative stress in chronic kidney disease
Ling, X. C., & Kuo, K.-L. (2018) · Renal Replacement Therapy · doi:10.1186/s41100-018-0195-2 · Cited by 183
Yamamoto, S., Zuo, Y., Ma, J., Yancey, P. G., Hunley, T. E., Motojima, M., Fogo, A. B., Linton, M. F., Fazio, S., Ichikawa, I., et al. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq759 · Cited by 74
“Differences between these results and previous reports describing vascular calcification in nephrectomized mice [39–41] may reflect more severe kidney dysfunction, differences relating to the method of renal ablation and/or difference in diet composition, which could affect levels of vitamin D, calcium and phosphate,…”
Result
Metadata
- Authors
- Phan, O., Ivanovski, O., Nguyen-Khoa, T., Mothu, N., Angulo, J., Westenfeld, R., Ketteler, M., Meert, N., Maizel, J., Nikolov, I. G., Vanholder, R., Lacour, B., Drüeke, T. B., & Massy, Z. A.
- Venue
- Circulation
- Published
- 2005-11
- Volume
- 112
- Issue
- 18
- Pages
- 2875-2882
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2097354630
- Cited by
- 148
- References
- 2
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E–Deficient Mice. https://app.cochat.ai/papers/10.1161/circulationaha105.541854
- The paper
- Phan, O., Ivanovski, O., Nguyen-Khoa, T., Mothu, N., Angulo, J., Westenfeld, R., Ketteler, M., Meert, N., Maizel, J., Nikolov, I. G., Vanholder, R., Lacour, B., Drüeke, T. B., & Massy, Z. A. (2005). Sevelamer Prevents Uremia-Enhanced Atherosclerosis Progression in Apolipoprotein E–Deficient Mice. Circulation. https://doi.org/10.1161/circulationaha105.541854
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.